MDMA and other psychostimulants continue to be popular drugs of abuse despite evidence in rodents and non-human primates that these agents produce a long-lasting depletion of brain serotonin (5-HT) and its major metabolite, 5-hydroxyindoleacetic acid. However, beyond this well-known finding, the mechanisms by which these agents produce 5-HT neurotoxicity remains unknown. There is evidence that the depletion of 5-HT in the brain is dependent, in part, upon the prolonged and excessive release of dopamine elicited by MDMA. The overall hypothesis that provides the basis for the studies proposed in this application is that the MDMA-induced depletion of brain 5-HT results from a) a MDMA-induced increase in the extracellular concentration of dopamine, b) the enzymatic or autoxidation of dopamine and the subsequent formation of hydroxyl-free radicals and c) the cellular damage (e.g., lipid peroxidation) associated with their formation. To provide evidence in support of the view that MDMA-induced 5-HT neurotoxicity results from oxidative stress to neurons following the generation of free radicals and depletion of endogenous antioxidants, the specific aims are to utilize in vivo microdialysis and biochemical assays to establish that 1) MDMA produces a dose- and time-dependent increase in the formation of hydroxyl free radicals in the brain, 2) MDMA-induced formation of hydroxyl free radicals is dependent, in part, upon the sustained increase in the extracellular concentration of dopamine, 3) MDMA-induced formation of hydroxyl free radicals is accompanied by free radical-mediated cellular toxicity, as evidenced by lipid peroxidation, decreased tissue concentrations of vitamin E and glutathione, and 4) MDMA-induced neurotoxicity of 5-HT neurons can be attenuated by prevention or inhibition of hydroxyl radical formation, treatment with free radical scavengers or treatment with iron chelators that diminish iron-facilitated autoxidation of dopamine. An understanding of the neurochemical substrates that mediate the neurotoxic effects of MDMA ultimately will assist in determining the risk to human health associated with its abuse and predicting neurotoxic consequences of other abused substances.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007427-05
Application #
2668133
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Frankenheim, Jerry
Project Start
1992-03-15
Project End
2000-02-29
Budget Start
1998-03-01
Budget End
1999-02-28
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Huff, Courtney L; Morano, Rachel L; Herman, James P et al. (2016) MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate. Neurotoxicology 57:282-290
Collins, Stuart A; Huff, Courtney; Chiaia, Nicolas et al. (2016) 3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling. J Neurochem 136:1074-84
Collins, Stuart A; Gudelsky, Gary A; Yamamoto, Bryan K (2015) MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors. Eur J Pharmacol 761:95-100
Anneken, John H; Cunningham, Jacobi I; Collins, Stuart A et al. (2013) MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J Neuroimmune Pharmacol 8:58-65
Huff, Courtney; Bhide, Nirmal; Schroering, Allen et al. (2013) Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake. Brain Res Bull 91:52-7
Anneken, John H; Gudelsky, Gary A (2012) MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology 63:1022-7
Schaefer, Tori L; Grace, Curtis E; Skelton, Matthew R et al. (2012) Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. ACS Chem Neurosci 3:12-21
Darvesh, Altaf S; Carroll, Richard T; Geldenhuys, Werner J et al. (2011) In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opin Drug Discov 6:109-127
Yamamoto, Bryan K; Moszczynska, Anna; Gudelsky, Gary A (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187:101-21
Schaefer, T L; Grace, C E; Gudelsky, G A et al. (2010) Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats. Stress 13:469-80

Showing the most recent 10 out of 58 publications